Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

715 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma-a multicenter analysis of the German working group "Stereotactic Radiotherapy".
Hoerner-Rieber J, Duma M, Blanck O, Hildebrandt G, Wittig A, Lohaus F, Flentje M, Mantel F, Krempien R, Eble MJ, Kahl KH, Boda-Heggemann J, Rieken S, Guckenberger M. Hoerner-Rieber J, et al. Among authors: hildebrandt g. J Thorac Dis. 2017 Nov;9(11):4512-4522. doi: 10.21037/jtd.2017.10.108. J Thorac Dis. 2017. PMID: 29268521 Free PMC article.
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J, Streblow J, Uhlmann L, Flentje M, Duma M, Ernst I, Blanck O, Wittig A, Boda-Heggemann J, Krempien R, Lohaus F, Klass ND, Eble MJ, Imhoff D, Kahl H, Petersen C, Gerum S, Henkenberens C, Adebahr S, Hass P, Schrade E, Wendt TG, Hildebrandt G, Andratschke N, Sterzing F, Guckenberger M. Rieber J, et al. Among authors: hildebrandt g. Lung Cancer. 2016 Jul;97:51-8. doi: 10.1016/j.lungcan.2016.04.012. Epub 2016 Apr 26. Lung Cancer. 2016. PMID: 27237028
Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease.
Rieber J, Abbassi-Senger N, Adebahr S, Andratschke N, Blanck O, Duma M, Eble MJ, Ernst I, Flentje M, Gerum S, Hass P, Henkenberens C, Hildebrandt G, Imhoff D, Kahl H, Klass ND, Krempien R, Lohaus F, Lohr F, Petersen C, Schrade E, Streblow J, Uhlmann L, Wittig A, Sterzing F, Guckenberger M. Rieber J, et al. Among authors: hildebrandt g. Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):511-520. doi: 10.1016/j.ijrobp.2016.09.026. Epub 2016 Sep 26. Int J Radiat Oncol Biol Phys. 2017. PMID: 27843031
Long-term Follow-up and Patterns of Recurrence of Patients With Oligometastatic NSCLC Treated With Pulmonary SBRT.
Hörner-Rieber J, Bernhardt D, Blanck O, Duma M, Eich HT, Gerum S, Gkika E, Hass P, Henkenberens C, Herold HU, Hildebrandt G, Imhoff D, Kahl H, Janssen S, Jurianz K, Krempien R, Lautenschläger SF, Lohaus F, Mueller AC, Petersen C, Sackerer I, Scafa D, Schrade E, Uhlmann L, Wittig A, Guckenberger M. Hörner-Rieber J, et al. Among authors: hildebrandt g. Clin Lung Cancer. 2019 Nov;20(6):e667-e677. doi: 10.1016/j.cllc.2019.06.024. Epub 2019 Jun 27. Clin Lung Cancer. 2019. PMID: 31327644
Direct dose correlation of MRI morphologic alterations of healthy liver tissue after robotic liver SBRT.
Boda-Heggemann J, Jahnke A, Chan MKH, Ghaderi Ardekani LS, Hunold P, Schäfer JP, Huttenlocher S, Wurster S, Rades D, Hildebrandt G, Lohr F, Dunst J, Wenz F, Blanck O. Boda-Heggemann J, et al. Among authors: hildebrandt g. Strahlenther Onkol. 2018 May;194(5):414-424. doi: 10.1007/s00066-018-1271-9. Epub 2018 Feb 5. Strahlenther Onkol. 2018. PMID: 29404626 English.
Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma.
Stera S, Balermpas P, Blanck O, Wolff R, Wurster S, Baumann R, Szücs M, Loutfi-Krauss B, Wilhelm ML, Seifert V, Rades D, Rödel C, Dunst J, Hildebrandt G, Arnold A, Meissner M, Kähler KC. Stera S, et al. Among authors: hildebrandt g. Melanoma Res. 2019 Apr;29(2):187-195. doi: 10.1097/CMR.0000000000000542. Melanoma Res. 2019. PMID: 30802230
In-vivo treatment accuracy analysis of active motion-compensated liver SBRT through registration of plan dose to post-therapeutic MRI-morphologic alterations.
Boda-Heggemann J, Jahnke A, Chan MKH, Ernst F, Ghaderi AL, Attenberger U, Hunold P, Schäfer JP, Wurster S, Rades D, Hildebrandt G, Lohr F, Dunst J, Wenz F, Blanck O. Boda-Heggemann J, et al. Among authors: hildebrandt g. Radiother Oncol. 2019 May;134:158-165. doi: 10.1016/j.radonc.2019.01.023. Epub 2019 Feb 15. Radiother Oncol. 2019. PMID: 31005210
Dosimetric Implications of Residual Tracking Errors During Robotic SBRT of Liver Metastases.
Chan M, Grehn M, Cremers F, Siebert FA, Wurster S, Huttenlocher S, Dunst J, Hildebrandt G, Schweikard A, Rades D, Ernst F, Blanck O. Chan M, et al. Among authors: hildebrandt g. Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):839-848. doi: 10.1016/j.ijrobp.2016.11.041. Epub 2016 Nov 27. Int J Radiat Oncol Biol Phys. 2017. PMID: 28244421
Clinical Results of Mean GTV Dose Optimized Robotic-Guided Stereotactic Body Radiation Therapy for Lung Tumors.
Baumann R, Chan MKH, Pyschny F, Stera S, Malzkuhn B, Wurster S, Huttenlocher S, Szücs M, Imhoff D, Keller C, Balermpas P, Rades D, Rödel C, Dunst J, Hildebrandt G, Blanck O. Baumann R, et al. Among authors: hildebrandt g. Front Oncol. 2018 May 17;8:171. doi: 10.3389/fonc.2018.00171. eCollection 2018. Front Oncol. 2018. PMID: 29868486 Free PMC article.
715 results